Literature DB >> 2307176

Interleukin 6 production in the central nervous system during experimental autoimmune encephalomyelitis.

K Gijbels1, J Van Damme, P Proost, W Put, H Carton, A Billiau.   

Abstract

Interleukin 6 (IL6) is one of the major inflammation-associated cytokines. Elevated serum or tissue levels of IL6 have been reported to occur in several human diseases, including infections of the central nervous system (CNS), but not in non-infectious CNS inflammation, e.g. multiple sclerosis. While studying experimental autoimmune encephalomyelitis (EAE) as an animal model for autoimmune inflammation of the CNS, we found increased IL6 levels in the CNS of mice suffering from a lethal form of the disease. IL6 levels in the spleens and sera were not significantly increased. These findings are indicative of local production of IL6 in the CNS during EAE, and represent the first demonstration of IL6 production in non-infectious CNS inflammatory disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2307176     DOI: 10.1002/eji.1830200134

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  30 in total

1.  Role of the JAKs/STATs pathway in the intracellular calcium changes induced by interleukin-6 in hippocampal neurons.

Authors:  D I Orellana; R A Quintanilla; C Gonzalez-Billault; R B Maccioni
Journal:  Neurotox Res       Date:  2005-11       Impact factor: 3.911

2.  Protective Effect of a cAMP Analogue on Behavioral Deficits and Neuropathological Changes in Cuprizone Model of Demyelination.

Authors:  Gelareh Vakilzadeh; Fariba Khodagholi; Tahereh Ghadiri; Marzieh Darvishi; Amir Ghaemi; Farshid Noorbakhsh; Ali Gorji; Mohammad Sharifzadeh
Journal:  Mol Neurobiol       Date:  2014-08-17       Impact factor: 5.590

3.  Role of toll-like receptors in multiple sclerosis.

Authors:  Socorro Miranda-Hernandez; Alan G Baxter
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

Review 4.  T-cell cytokines in injury-induced neural damage and repair.

Authors:  Michael Schroeter; Sebastian Jander
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

5.  Immunopathology of experimental African sleeping sickness: detection of cytokine mRNA in the brains of Trypanosoma brucei brucei-infected mice.

Authors:  C A Hunter; J W Gow; P G Kennedy; F W Jennings; M Murray
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

6.  Immunohistochemical localization of interleukin-6-like immunoreactivity to peripheral nerve-like structures in normal and inflamed human skin.

Authors:  K Nordlind; L B Chin; A A Ahmed; J Brakenhoff; E Theodorsson; S Lidén
Journal:  Arch Dermatol Res       Date:  1996-07       Impact factor: 3.017

7.  Spinal activity of interleukin 6 mediates myelin basic protein-induced allodynia.

Authors:  Justin S Ko; Kelly A Eddinger; Mila Angert; Andrei V Chernov; Jennifer Dolkas; Alex Y Strongin; Tony L Yaksh; Veronica I Shubayev
Journal:  Brain Behav Immun       Date:  2016-03-09       Impact factor: 7.217

Review 8.  Interleukin-6 in autoimmune disease. Role of IL-6 in physiology and pathology of the immune defense.

Authors:  L Graeve; M Baumann; P C Heinrich
Journal:  Clin Investig       Date:  1993-08

9.  Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice.

Authors:  J E Merrill; D H Kono; J Clayton; D G Ando; D R Hinton; F M Hofman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

10.  Chronic interleukin-6 alters NMDA receptor-mediated membrane responses and enhances neurotoxicity in developing CNS neurons.

Authors:  Z Qiu; D D Sweeney; J G Netzeband; D L Gruol
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.